HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Business (Cosmetics)

Deals

Set Alert for Deals (Beauty)

Latest From Beauty & Deals

More ‘Visibility’ For Investors Into Standalone J&J Consumer Business Needed For Growth – CEO

“There's been not enough investors' visibility to our consumer health business," recently promoted CEO Duato says at JP Morgan conference, With separate business, "investors are going to see the strength of our consumer health business, the number of iconic brands, the global scale and our penetration, the unique relationship that consumer have with our brands."

OTC Drugs M & A

German Women's Supplements Specialist InnoNature Secures Private-Equity Backing

Germany's Innonature - which develops and markets supplements, superfoods and cosmetics for women - has been snapped up by Northern European private-equity firm Verdane.

Deals Europe

EU Business News: Nestlé Cuts L'Oréal Stake, Stada Sets Up In Sweden

The latest news from Europe's health, beauty and wellness markets: Nestlé is reducing its stake in L'Oréal to fund an expanded share buyback program; and Stada has opened in office in Sweden to manage the distribution and marketing of a portfolio of well-established Sanofi brands.

Europe Business Strategies
See All

Strategy

Set Alert for Strategy (Beauty)

Latest From Beauty & Business Strategies

Floss By Any Other Name Would Sell In Same Category – BBB National Programs Appeals Panel

NARB panel concluded #1 claims challenged by Oral-B floss products marketer P&G aren’t supported by acceptable evidence that the type of product the claim referenced – flossers  – “is recognized as a consumer-relevant category."

OTC Devices Ad Complaints

L’Oréal Tackles Age-Old Problems With Home Hair Color, Spurred By Pandemic Demand

The French beauty giant plans to launch its Colorsonic at-home hair color device with oscillating nozzle in early 2023. L’Oreal showcased the product, along with a breakthrough hair color “reader” and custom mixing system for salon use, at the CES 2022 tech show in Las Vegas.

Beauty Innovation

More ‘Visibility’ For Investors Into Standalone J&J Consumer Business Needed For Growth – CEO

“There's been not enough investors' visibility to our consumer health business," recently promoted CEO Duato says at JP Morgan conference, With separate business, "investors are going to see the strength of our consumer health business, the number of iconic brands, the global scale and our penetration, the unique relationship that consumer have with our brands."

OTC Drugs M & A
See All

Sales & Earnings

Set Alert for Sales & Earnings (Beauty)

Latest From Beauty & Sales & Earnings

Coty’s FY 2023 Will Be ‘Year Of Skin Care’; Reinstated ‘Powerhouse’ Says Growth Engines Are Fired

Doubts about Coty’s “viability” have melted away with the return to growth of its Consumer Beauty division and momentum in its burgeoning skin-care and prestige cosmetics businesses. Coty now aims to beat the market with 6% to 8% compound annual revenue growth from fiscal 2022 through 2025.

Beauty Business Strategies

E.l.f. Cosmetics Will Be ‘100% Clean’ Going Into 2022; Q2 Sales Up 27% To $92M

E.l.f.’s core consumer proposition continues to focus on quality, innovative products at accessible prices, but the company also has been working to strengthen its “clean” credentials, reformulating more than 350 SKUs in recent months to ensure that its namesake brand is “100% clean” by year-end.

United States Sales & Earnings

Prestige Links Sales Growth To Retailer, Consumer Supply-Chain Fears

Retailer and consumer stockpiling in fear of supply chain disruptions drive double digit consumption growth for Prestige Consumer Healthcare’s Dramamine, Nix, Hydralyte and cough/cold brands. Brands drove total sales up 10.5% excluding impact of Akorn, to $12.4m in latest quarter. 

Coronavirus COVID-19 OTC Drugs
See All
UsernamePublicRestriction

Register